https://www.biospace.com/article/preliminary-findings-point-to-low-risk-of-secondary-cancers-from-car-t-therapies-/
New research from the University of Pennsylvania and Stanford University finds no link between CAR-T cell therapies and the development of secondary T-cell malignancies.
- Forums
- ASX - By Stock
- Chimeric: Media Thread
https://www.biospace.com/article/preliminary-findings-point-to-lo...
-
- There are more pages in this discussion • 194 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add CHM (ASX) to my watchlist
(20min delay)
|
|||||
Last
1.4¢ |
Change
0.000(0.00%) |
Mkt cap ! $12.67M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Featured News
CHM (ASX) Chart |
Day chart unavailable